Gamida Loses "Major Pharma" Buyer Said to Be Novartis
The largest shareholder in Gamida Cell said today through its parent company that talks with “a global pharmaceutical company” to buy the Jerusalem-based stem cell drug developer have broken down, halting earl…
Read guide →